SCHEMBL9614625

SCHEMBL9614625

CCCCNC(=O)Cc1ccc(O)cc1

nearest known ligand 0.76

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.76
▸ CA1 P00915 1/20 0.64
▸ CA2 P00918 1/20 0.64
▸ TRPV1 Q8NER1 2/20 0.61
▸ ESRRB O95718 1/20 0.57
▸ ESRRG P62508 1/20 0.57
▸ RAB9A P51151 1/20 0.52
▸ GAA P10253 1/20 0.51
▸ CDK5 Q00535 1/20 0.51
▸ CDK5R1 Q15078 1/20 0.51
▸ HDAC4 P56524 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ LMNA P02545 2/20 0.50
▸ ATM Q13315 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194399 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL8375073 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL7268989 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL7268933 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL7263369 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL7262810 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL8374584 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL7270390 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL10947025 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB
SCHEMBL7271175 0.93 TRPV1 (0.71) HPGDCA1CA2TRPV1ESRRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0476007-A4 CATALYTIC ANTIBODIES — 1992-05-20 — — EP disclosed
EP-0476007-A1 CATALYTIC ANTIBODIES THERAPEUTIC ANTIBODIES INC. (US) 1992-03-25 — — EP disclosed
WO-1990015134-A1 CATALYTIC ANTIBODIES THERAPEUTIC ANTIBODIES, INC. (US) 1990-12-13 — — WO disclosed
Send feedback